newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has successfully completed